Bio-Rad Laboratories, Inc. (BIO) Misses Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $386.11 -0.46%
EPS Growth %: +5.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Laboratories, Inc. (NYSE: BIO) reported Q1 EPS of $1.16, $0.16 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $485.1 million versus the consensus estimate of $482.11 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Brady Corp. (BRC) Tops Q4 EPS by 1c ; Offers Guidance
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
